These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35084805)

  • 1. Metabolic control during the SARS-CoV-2 lockdown in a large German cohort of pediatric patients with type 1 diabetes: Results from the DPV initiative.
    Hammersen J; Reschke F; Tittel SR; Pappa A; Dost A; Köstner K; Rosenbauer J; Kapellen TM; Rohrer TR; Holl RW
    Pediatr Diabetes; 2022 May; 23(3):351-361. PubMed ID: 35084805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic control during the first two years of the COVID-19 pandemic in pediatric patients with type 1 diabetes: results from the German DPV initiative.
    Hammersen J; Tittel SR; Khodaverdi S; Reschke F; Flury M; Menzel U; Mönkemöller K; Meissner T; Karges B; Holl RW
    Acta Diabetol; 2023 Jun; 60(6):757-766. PubMed ID: 36871116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020.
    Nwosu BU; Al-Halbouni L; Parajuli S; Jasmin G; Zitek-Morrison E; Barton BA
    Front Endocrinol (Lausanne); 2021; 12():703905. PubMed ID: 34447352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of lockdown due to COVID-19 on glucose patterns among children, adolescents, and adults with type 1 diabetes: CGM study.
    Di Dalmazi G; Maltoni G; Bongiorno C; Tucci L; Di Natale V; Moscatiello S; Laffi G; Pession A; Zucchini S; Pagotto U
    BMJ Open Diabetes Res Care; 2020 Oct; 8(2):. PubMed ID: 33115820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of a prolonged lockdown and use of telemedicine on glycemic control in people with type 1 diabetes during the COVID-19 outbreak in Saudi Arabia.
    Alharthi SK; Alyusuf EY; Alguwaihes AM; Alfadda A; Al-Sofiani ME
    Diabetes Res Clin Pract; 2021 Mar; 173():108682. PubMed ID: 33539868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from the continuous glucose monitoring metrics in pediatric patients with type 1 diabetes under COVID-19 lockdown.
    Brener A; Mazor-Aronovitch K; Rachmiel M; Levek N; Barash G; Pinhas-Hamiel O; Lebenthal Y; Landau Z
    Acta Diabetol; 2020 Dec; 57(12):1511-1517. PubMed ID: 33026497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 Lockdown Periods in 2020: Good Maintenance of Metabolic Control in Adults with Type 1 and Type 2 Diabetes.
    Hartmann B; Tittel SR; Femerling M; Pfeifer M; Meyhöfer S; Lange K; Milek S; Stemler L; Best F; Holl RW
    Exp Clin Endocrinol Diabetes; 2022 Sep; 130(9):621-626. PubMed ID: 35181878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of COVID-19 lockdown on flash and real-time glucose sensor users with type 1 diabetes in England.
    Prabhu Navis J; Leelarathna L; Mubita W; Urwin A; Rutter MK; Schofield J; Thabit H
    Acta Diabetol; 2021 Feb; 58(2):231-237. PubMed ID: 33067723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of COVID-19 lockdown on glucemic control in children and adolescents with type 1 diabetes mellitus.
    Sánchez Conejero M; González de Buitrago Amigo J; Tejado Bravo ML; de Nicolás Jiménez JM
    An Pediatr (Engl Ed); 2022 Jul; 97(1):22-29. PubMed ID: 35725820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry.
    Sandig D; Grimsmann J; Reinauer C; Melmer A; Zimny S; Müller-Korbsch M; Forestier N; Zeyfang A; Bramlage P; Danne T; Meissner T; Holl RW
    Diabetes Technol Ther; 2020 Aug; 22(8):602-612. PubMed ID: 32522039
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of COVID-19 lockdown on glycemic control in type 1 diabetes.
    Duarte V; Mota B; Ferreira S; Costa C; Correia CC
    Arch Pediatr; 2022 Jan; 29(1):27-29. PubMed ID: 34955306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term glycemic control and glucose variability assessed with continuous glucose monitoring in a pediatric population with type 1 diabetes: Determination of optimal sampling duration.
    Piona C; Marigliano M; Mozzillo E; Franzese A; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Delvecchio M; Maffeis C
    Pediatr Diabetes; 2020 Dec; 21(8):1485-1492. PubMed ID: 32935887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
    DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
    Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes.
    Fernández E; Cortazar A; Bellido V
    Diabetes Res Clin Pract; 2020 Aug; 166():108348. PubMed ID: 32711000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring.
    Mesa A; Viñals C; Pueyo I; Roca D; Vidal M; Giménez M; Conget I
    Diabetes Res Clin Pract; 2020 Sep; 167():108354. PubMed ID: 32739380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative.
    DeSalvo DJ; Lanzinger S; Noor N; Steigleder-Schweiger C; Ebekozien O; Sengbusch SV; Yayah Jones NH; Laubner K; Maahs DM; Holl RW
    Diabetes Technol Ther; 2022 Dec; 24(12):920-924. PubMed ID: 35947079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Has COVID-19 lockdown improved glycaemic control in pediatric patients with type 1 diabetes? An analysis of continuous glucose monitoring metrics.
    Lombardo F; Salzano G; Bombaci B; Basile P; Lucania G; Alibrandi A; Passanisi S
    Diabetes Res Clin Pract; 2021 Aug; 178():108988. PubMed ID: 34331977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
    Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
    Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic control in children and teenagers with type 1 diabetes around lockdown for COVID-19: A continuous glucose monitoring-based observational study.
    Wu X; Luo S; Zheng X; Ding Y; Wang S; Ling P; Yue T; Xu W; Yan J; Weng J
    J Diabetes Investig; 2021 Sep; 12(9):1708-1717. PubMed ID: 33539665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents: A group-based modeling approach.
    Clements MA; Schwandt A; Donaghue KC; Miller K; Lück U; Couper JJ; Foster N; Schröder C; Phelan H; Maahs D; Prinz N; Craig ME;
    Pediatr Diabetes; 2019 Nov; 20(7):920-931. PubMed ID: 31418521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.